American Association for Physician Leadership

Quality and Risk

Quality of Inpatient Bowel Preparation for Colonoscopy at an Academic Center: An Opportunity for Improvement

Syed Kashif Mahmood, MD, MPH | Emily J. Campbell, MPH | James M. Richter, MD

October 8, 2017


Abstract:

Inpatient status is known to be an independent predictor of poor bowel preparation quality, and there are limited data on predictors of bowel preparation. Our goal was to study the effectiveness of bowel preparation and the clinical and practice variables affecting bowel preparation quality. We studied 335 consecutive inpatients undergoing colonoscopy in a tertiary hospital to assess the quality of bowel preparation. The observed effectiveness of bowel preparation was below institutional and published standards. Statistically significant variables affecting bowel preparation quality include gender (multivariable p = .018), indication for colonoscopy (p = .028), and time interval between initiation of both polyethylene glycol preparation and colonoscopy (p = .002). We found that hospitalized patients—except those with gastrointestinal bleeding—have much poorer bowel preparation than outpatients. In addition, the time interval between start of polyethylene glycol preparation and colonoscopy helps determine the inpatient bowel preparation quality. Inpatient colonoscopies may not be adequate to exclude small polyps or to be included in a systematic colorectal cancer screening and prevention program.




Colonoscopy currently is the principal diagnostic technique for most colonic diseases. For an optimal examination, the bowel requires “preparation” by clearing it of all fecal material. Consensus guidelines have identified inpatient status as an independent predictor of poor bowel preparation.(1-3) Hospitalized patients generally tend to be older and have more chronic disease.(4) These differences indicate that inpatients may warrant special considerations when preparing the bowel prior to colonoscopy. An understanding of the challenges is important, because inadequate bowel cleansing may lead to canceled procedures, overlooked lesions, increased procedural times (prolonged cecal intubation and withdrawal times), and potentially increased complication rates.(5,6)

Optimal bowel preparation should clear the colon of all fecal matter, should not cause damage to the mucosa, and should be easy to administer without adverse effects.(7) However, to date no bowel preparation has demonstrated all these characteristics. Polyethylene glycol (PEG) has become part of preferred colonoscopy preparation (inpatient as well as outpatient) worldwide. The standard of four liters of PEG beginning the day before the procedure has been found to be both safe and effective.(2,8) PEG has been safely used in patients with renal dysfunction, quiescent inflammatory bowel disease, and lower gastrointestinal hemorrhage, providing an advantage over other purgatives for many hospitalized patients with renal insufficiency, liver insufficiency, or heart failure.(8) However, because PEG relies on high-volume lavage, patients’ ability to tolerate it remains a significant issue: an estimated 5% to 25% of patients are unable to complete a PEG preparation.(2,9)

In response to the lack of studies about inpatient bowel preparation, we aimed to measure the quality of bowel preparation and explore variables affecting bowel preparation for hospitalized patients undergoing colonoscopy. We sought to identify subgroups of patients at higher risk for poor bowel preparation so as to focus strategies for improvement.

Methods

We report an observational study designed to look at variables affecting the quality of bowel preparation for inpatient colonoscopy. The study was conducted at Massachusetts General Hospital in Boston, Massachusetts, and was approved by the hospital’s Institutional Review Board.

All hospitalized patients undergoing colonoscopy were eligible to be included in the study. Electronic medical records were used to gather individual data points, which were logged in a study database. Exclusion criteria (Figure 1) included flexible sigmoidoscopies, cases performed outside of the endoscopy suite (e.g., in intensive care units or operating rooms), and patients who did not receive PEG prior to colonoscopy. Any procedure aborted for reasons other than poor bowel preparation also was excluded. Additionally, for patients who underwent colonoscopy more than once during the same hospitalization, we recorded only the preparation and outcomes from the first procedure to avoid adding confounding information from the second procedure. General demographic data (age, gender, race, and marital status) were collected, as well as the reason for inpatient gastroenterology consultation, and the indication for colonoscopy. We analyzed diet orders 24 hours prior to colonoscopy and grouped patients into fasting (NPO), clear liquids, or “other.” Information on narcotic medications also was collected, as were data on any laxative that patient had received within two days prior to colonoscopy (Table 1). The time between bowel preparation and colonoscopy was measured by the difference between the time stamp marking the start of PEG administration and the time stamp for the start of the colonoscopy.

Figure 1. Patient cohort methodology. ER, emergency room; ICU, intensive care unit;
OR, operating room.

The recommended preparation for inpatients was a diet of clear liquids beginning the afternoon prior to the procedure, followed by 10 mg of bisacodyl and 4 liters of PEG (Nulytely) in the evening. This protocol differed from our outpatient regimen at the time due to the shorter period of the clear liquid diet and the addition of bisacodyl. Additional PEG was given the morning of the examination if the floor nurses thought that the preparation was incomplete.

The primary study outcome was bowel preparation quality. Our center uses a modified version of the five-point Aronchick scale for bowel preparation grading, which divides bowel preparation quality into five grades: unsatisfactory, poor, fair, good, and excellent.(10) The colonoscopist’s assessment of quality was made after intra-examination cleansing and is a required element for a complete report. We dichotomized these descriptions as either “acceptable” (those rated as excellent or good) or “not acceptable” (those rated as fair, poor, or unsatisfactory).

Investigators collected data over a 10-month period. The initial sample included 377 consecutive patients undergoing inpatient colonoscopy (not including sigmoidoscopies and procedures performed outside the endoscopy unit); further application of exclusion criteria (Figure 1) yielded a final sample size of 335 patients. Thirty-eight endoscopists plus four fellows under their supervision performed colonoscopies during the study period.

We constructed both univariate and multivariable logistic regression models (dependent variables listed in Table 2) with bowel preparation quality as the outcome variable. Odds ratios and their confidence intervals were then generated. We considered p values of less than .05 as statistically significant. Investigators used STATA13 (StataCorp LP, College Station, Texas) for all calculations.

Results

We evaluated bowel preparation rates in our inpatient sample. The percentage of patients graded as “excellent” was 4% (n = 14), and those graded as “good” was 48% (n = 160) per the modified Aronchick scale, for a total of 52% (n = 176) acceptable preps. Of the remaining patients, 29% (n = 97) had a “fair” preparation, and 19% (n = 64) had a poor or otherwise unsatisfactory preparation, for a total of 48% unacceptable. A contemporaneous group of 7067 outpatient exams during the same time period scored 81% acceptable preparation (“good” or “excellent”), which we include as a reference point for physician use of the modified Aronchick scale. The patients were fundamentally different and not comparable, but these outpatient data demonstrate the expected preparation rate for performance of an accurate colonoscopy.

Gender was a significant variable (p = .02), with females presenting for colonoscopy with better quality bowel preparation [OR=1.785; 95% CI (1.105, 2.88)]. This was a significant variable despite adjustment for age, race, and marital status, which were not significant variables.

The indications for colonoscopy included hematochezia (43%), melena (23%), anemia (7%), diarrhea (7%), inflammatory bowel disease (3%), abdominal pain (10%), anticoagulation risk assessment (3%), and other (12%). Some patients had multiple indications recorded. Indication for colonoscopy was a significant variable when dichotomized by lower gastrointestinal bleeding (LGIB) vs. non-LGIB indications (p = .03). Objective measures of LGIB were defined as a visual or occult test confirmation of the presence of blood in stool. Patients with anemia who did not have direct evidence of blood in the stool were not included in this definition of LGIB. Statistical analysis further revealed that patients who had LGIB as a documented indication for colonoscopy were significantly more likely [OR=1.742; 95% CI (1.062, 2.857)] to have higher-quality bowel preparation. In our sample, LGIB was the most common indication (58%) for inpatient colonoscopy. There were insufficient cases to consider emergent cases separately.

The time interval between start of bowel preparation and start of colonoscopy was a strong predictor (multivariable p = .002) of bowel preparation quality (Figure 2). In an attempt to explore the time interval issue further, we dichotomized time interval as greater than 24 hours and less than or equal to 24 hours. In this case, time remained a statistically significant variable (multivariable p = .002), with shorter-interval patients prepping better [OR=2.114; 95% CI (1.328, 3.366)]. We also dichotomized time intervals into greater than 14 hours and less than or equal to 14 hours, which was found to be not statistically significant (multivariable p = .42).

Figure 2. Box plots of time intervals between initiation of both bowel preparation and colonoscopy grouped by bowel preparation quality.

Notably, prior studies have identified an ideal time interval between bowel preparation and start of procedure.(11,12) Although our data agree that shorter time intervals are better, we did not find statistical significance for high-quality bowel preparation when the interval is shortened to less than 14 hours. Our data indicated that the majority of patients (67.0%) started bowel preparation between 4:00 PM and midnight, with the bulk (41.0% of all patients) beginning between 6:00 PM and midnight. Additionally, in terms of colonoscopy start times, the majority of patients (63.3%) underwent colonoscopy in the afternoon (noon to 6:00 PM).

Discussion

Our results are consistent with published evidence suggesting that inpatients have poorer-quality bowel preparation than outpatients.(1-4,13) Hendry et al.(13) noted that the proportion of inpatients with “good” bowel preparation was only 64%, in contrast to 86% rates of acceptable outpatient bowel preparation. Inpatients experience a higher incidence of incomplete or repeat colonoscopy, are less adherent to preparation instructions, and are more often judged to have poor preparation quality.(4) Focusing on inpatients may have implications not just for colonoscopy outcomes but also for inpatient cost (by avoiding need for repeat colonoscopies).(14) Additionally, inpatient examinations, although often adequate for the immediate diagnostic purposes, may not be sufficient for polyp and colorectal cancer screening. CMS is considering rules that report and regulate the frequency of colonoscopy for screening purposes. These data suggest that inpatient colonoscopies may be adequate for diagnostic purposes, but they are not adequate to exclude small polyps or be included in a systematic colorectal cancer screening and prevention program.

Several factors have been proposed to explain this discrepancy between inpatient and outpatient bowel preparation. Hospitalized patients tend to be older, and this patient population has been found to have a higher incidence of poor colonic preparation.(15) Inpatients also are less mobile and have more chronic disease. Other contributory factors include bed rest, higher likelihood of constipation, and possible use of narcotics. Hospitalized patients also differ from outpatients in terms of indication for procedure. For inpatients, common indications include LGIB, weight loss, iron deficiency anemia, abnormal imaging, and chronic diarrhea, in contrast with outpatient colonoscopies, which are commonly performed for malignancy screening or to assess inflammatory bowel disease.

Some common predictors of poor bowel preparation (applicable to both inpatients and outpatients) include male gender; use of tricyclic antidepressants; later colonoscopy start time; procedural indication of constipation; and a history of stroke, cirrhosis or dementia.(16,17) Patients also cite the bowel preparatory solution itself as a major barrier to undergoing colonoscopy.(9,18-20) A history of diabetes, appendectomy, colorectal resection, or hysterectomy was an independent predictor of poor bowel preparation.(21) In contrast, patients undergoing colonoscopy for lower gastrointestinal bleeding had better results, perhaps because of the motivation of perceived urgency or the cathartic effect of blood.

As has been noted by other authors, our data also found the time interval between start of bowel preparation and start of colonoscopy to be a strongly significant variable affecting bowel preparation quality.(12, 22) This is a challenge for hospitalized patients, because this patient population rarely is admitted for the sole purpose of colonoscopy, and bowel preparation needs to compete with other planned inpatient investigations. Bowel preparation start time often is based on timing of consultation, indication for procedure, and the availability of endoscopy. Outpatient guidelines have recommended keeping the interval between the last dose of bowel preparation and colonoscopy as short as possible.(23) Although some have advocated for ingestion of all of PEG solution on the day of colonoscopy for an afternoon procedure, others recommend split dosing.(24-27) Some authors recommend that bowel preparations be given in the morning of the colonoscopy. It also is notable that right-sided colon cleansing has been found to be significantly better with morning preparation.(28)

Published literature suggests that laxatives (e.g., Senna), when used, may improve cleansing.(29) Other authors also have pointed to beneficial effects of adjunct laxative use with PEG preparations(30); however, our study did not find adjunct laxative use to be a significant variable affecting inpatient bowel preparation quality (multivariable p = .82). Additionally, evidence shows that a low-fiber diet the day before colonoscopy may improve preparation tolerability.(31) Park et al.(32) also showed that a low-residue diet was at least as good as a clear-liquid diet the day prior to colonoscopy. However, it is not always possible to provide hospitalized patients dietary modifications for an entire day prior to their procedure. Our study also did not find that diet had significant effect on bowel preparation quality (multivariable p = .94). Additional study is needed to determine an efficient and optimal preparation for inpatients undergoing colonoscopy.

Conclusion

Prior studies have found that compared with outpatients, hospitalized patients have more difficulty preparing for colonoscopy, because they are older, dependent on others for personal care assistance, and have more chronic disease. Although this study is limited by its observational design, our results underscore the notion that bowel preparation for inpatients remains a challenge. The impact of poor preparation includes the potential of overlooking dangerous colonic lesions and increased cost of care.(32) In our cohort, patients with LGIB and female patients were better prepared for colonoscopy, suggesting the need for more aggressive preparation regimens for certain inpatients.

Acknowledgement. The authors wish to acknowledge the contribution of Hui Zheng PhD, Assistant Professor, Biostatistics Center, Massachusetts General Hospital, Department of Medicine, Harvard Medical School.

References

  1. Johnson DA, Barkun AN, Cohen LB, et al. Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the US multi-society task force on colorectal cancer. Gastroenterol. 2014;147:903-924.

  2. American Society of Colon and Rectal Surgeons (ASCRS), American Society for Gastrointestinal Endoscopy (ASGE), Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), Wexner SD, Beck DE, Baron TH, et al. A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Surg Endosc. 2006;20:1147-1160.

  3. Connor A, Tolan D, Hughes S, Carr N, Tomson C. Consensus guidelines for the safe prescription and administration of oral bowel-cleansing agents. Gut. 2012;61:1525-1532.

  4. Chorev N, Chadad B, Segal N, et al. Preparation for colonoscopy in hospitalized patients. Dig Dis Sci. 2007;52:835-839.

  5. Chiu HM, Lin JT, Wang HP, Lee YC, Wu MS. The impact of colon preparation timing on colonoscopic detection of colorectal neoplasms—a prospective endoscopist-blinded randomized trial. Am J Gastroenterol. 2006;101:2719-2725.

  6. Weber FH Jr. Optimizing colonic preparation: the solution is becoming clearer and clearer. Clin Gastroenterol Hepatol. 2011;9:286-289.

  7. Tan JJ, Tjandra JJ. Which is the optimal bowel preparation for colonoscopy - a meta-analysis. Colorectal Dis. 2006;8(4):247-258.

  8. Brown AR, DiPalma JA. Bowel preparation for gastrointestinal procedures. Curr Gastroenterol Rep. 2004;6(5):395-401.

  9. Aronchick CA, Lipshutz WH, Wright SH, Dufrayne F, Bergman G. A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda. Gastrointest Endosc. 2000;52:346-352.

  10. Rostom A, Jolicoeur E. Validation of a new scale for the assessment of bowel preparation quality. Gastrointest Endosc. 2004;59:482-486.

  11. Holt EW, Verhille MS. Improving the quality of bowel preparation: one step closer to the holy grail? Dig Dis Sci. 2011;56:273-275.

  12. Eun CS, Han DS, Hyun YS, et al. The timing of bowel preparation is more important than the timing of colonoscopy in determining the quality of bowel cleansing. Dig Dis Sci. 2011;56:539-544.

  13. Hendry PO, Jenkins JT, Diament RH. The impact of poor bowel preparation on colonoscopy: a prospective single-centre study of 10,571 colonoscopies. Colorectal Dis. 2007;9:745-748.

  14. Rex DK, Imperiale TF, Latinovich DR, Bratcher LL. Impact of bowel preparation on efficiency and cost of colonoscopy. Am J Gastroenterol. 2002;97:1696-1700.

  15. Lukens FJ, Loeb DS, Machicao VI, Achem SR, Picco MF. Colonoscopy in octogenarians: a prospective outpatient study. Am J Gastroenterol. 2002;97:1722-1725.

  16. Ness RM, Manam R, Hoen H, Chalasani N. Predictors of inadequate bowel preparation for colonoscopy. Am J Gastroenterol. 2001;96:1797-1802.

  17. Lebwohl B, Wang TC, Neugut AI. Socioeconomic and other predictors of colonoscopy preparation quality. Dig Dis Sci. 2010;55:2014-2020.

  18. Siddiqui AA, Yang K, Spechler SJ, et al. Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality. Gastrointest Endosc. 2009;69(3 Pt 2):700-706.

  19. Aisenberg J. Bowel preparation for colonoscopy: shortening the “runway time.” Gastrointest Endosc. 2009;69(3 Pt 2):707-709.

  20. Chung YW, Han DS, Park KH, et al. Patient factors predictive of inadequate bowel preparation using polyethylene glycol: a prospective study in Korea. J Clin Gastroenterol. 2009;43:448-452.

  21. Parra-Blanco A, Nicolas-Perez D, Gimeno-Garcia A, et al. The timing of bowel preparation before colonoscopy determines the quality of cleansing, and is a significant factor contributing to the detection of flat lesions: A randomized study. World J Gastroenterol. 2006;12:6161-6166.

  22. Hassan C, Bretthauer M, Kaminski MF, et al. Bowel preparation for colonoscopy: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2013;45:142-150.

  23. Gurudu SR, Ratuapli S, Heigh R, DiBaise J, Leighton J, Crowell M. Quality of bowel cleansing for afternoon colonoscopy is influenced by time of administration. Am J Gastroenterol. 2010;105:2318-2322.

  24. Varughese S, Kumar AR, George A, Castro FJ. Morning-only one-gallon polyethylene glycol improves bowel cleansing for afternoon colonoscopies: a randomized endoscopist-blinded prospective study. Am J Gastroenterol. 2010;105:2368-2374.

  25. Cohen LB. Split dosing of bowel preparations for colonoscopy: an analysis of its efficacy, safety, and tolerability. Gastrointest Endosc. 2010;72:406-412.

  26. Khan MA, Piotrowski Z, Brown MD. Patient acceptance, convenience, and efficacy of single-dose versus split-dose colonoscopy bowel preparation. J Clin Gastroenterol. 2010;44:310-311.

  27. Gupta T, Mandot A, Desai D, Abraham P, Joshi A, Shah S. Comparison of two schedules (previous evening versus same morning) of bowel preparation for colonoscopy. Endoscopy. 2007;39:706-709.

  28. Radaelli F, Meucci G, Imperiali G, et al. High-dose senna compared with conventional PEG-ES lavage as bowel preparation for elective colonoscopy: a prospective, randomized, investigator-blinded trial. Am J Gastroenterol. 2005;100:2674-2680.

  29. Adams WJ, Meagher AP, Lubowski DZ, King DW. Bisacodyl reduces the volume of polyethylene glycol solution required for bowel preparation. Dis Colon Rectum. 1994;37:229-234.

  30. Soweid AM, Kobeissy AA, Jamali FR, et al. A randomized single-blind trial of standard diet versus fiber-free diet with polyethylene glycol electrolyte solution for colonoscopy preparation. Endoscopy. 2010;42:633-638.

  31. Park DI, Park SH, Lee SK, et al. Efficacy of prepackaged, low residual test meals with 4L polyethylene glycol versus a clear liquid diet with 4L polyethylene glycol bowel preparation: A randomized trial. J Gastroenterol Hepatol. 2009;24:988-991.

  32. Harewood GC, Sharma VK, de Garmo P. Impact of colonoscopy preparation quality on detection of suspected colonic neoplasia. Gastrointest Endosc. 2003;58:76-79.

This article is available to AAPL Members.

Log in to view.

Syed Kashif Mahmood, MD, MPH

Lahey Clinic and Medical Center, Department of Medicine-Gastroenterology, Burlington, Massachusetts.


Emily J. Campbell, MPH

Massachusetts General Hospital, Department of Medicine-Gastroenterology, Boston, Massachusetts.


James M. Richter, MD

Massachusetts General Hospital, Department of Medicine-Gastroenterology, 55 Fruit Street, Blake 4, Boston, MA 02114; phone: 617-726-0229; e-mail: jrichter@mgh.harvard.edu.

Interested in sharing leadership insights? Contribute



For over 45 years.

The American Association for Physician Leadership has helped physicians develop their leadership skills through education, career development, thought leadership and community building.

The American Association for Physician Leadership (AAPL) changed its name from the American College of Physician Executives (ACPE) in 2014. We may have changed our name, but we are the same organization that has been serving physician leaders since 1975.

CONTACT US

Mail Processing Address
PO Box 96503 I BMB 97493
Washington, DC 20090-6503

Payment Remittance Address
PO Box 745725
Atlanta, GA 30374-5725
(800) 562-8088
(813) 287-8993 Fax
customerservice@physicianleaders.org

CONNECT WITH US

LOOKING TO ENGAGE YOUR STAFF?

AAPL providers leadership development programs designed to retain valuable team members and improve patient outcomes.

American Association for Physician Leadership®

formerly known as the American College of Physician Executives (ACPE)